全球qPCR試劑市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計 qPCR 試劑市場將從 2025 年的 39.5 億美元成長到 2034 年的 84.7 億美元，2026 年至 2034 年的複合年成長率為 8.84%。

由於全球對分子診斷檢測的需求不斷成長，全球qPCR試劑市場正經歷顯著成長。感染疾病的蔓延推動了臨床檢查室檢測量的增加，而基因組學和生物技術領域研究活動的拓展也促進了試劑的消耗。此外，新冠疫情也加速了人們對先進分子診斷技術的認知與應用。這些因素共同推動了整體市場成長。

關鍵促進因素包括個人化醫療和精準診斷的進步。製藥和生物技術公司在藥物研發和檢驗過程中高度依賴qPCR技術。政府對生命科學研究投入的增加帶動了檢查室投資的成長。技術進步提高了檢測的靈敏度、準確性和可靠性。新興經濟體診斷基礎設施的不斷改善也支撐了市場需求。

由於在癌症治療和基因檢測領域的應用不斷擴展，未來前景仍然光明。實驗室自動化將顯著提高處理能力和效率。多種檢測方法的開發有望帶來更多成長機會。新興市場對醫療基礎設施的投資正在不斷加強。分子生物學工具的持續創新可望支撐其長期發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球qPCR試劑市場：依產品類型分類

• 市場分析、洞察與預測
• 母帶混音
• 引子和探針
• 酵素
• 緩衝
• 其他

第5章：全球qPCR試劑市場：依應用分類

• 市場分析、洞察與預測
• 臨床診斷
• 藥物研究
• 環境監測
• 農業生物技術
• 食品安全檢查

第6章：全球qPCR試劑市場：依技術分類

• 市場分析、洞察與預測
• 即時PCR（qPCR）
• 數位PCR（dPCR）
• 多重PCR
• 逆轉錄聚合酵素鏈鎖反應（RT-PCR）

第7章：全球qPCR試劑市場：依最終用戶分類

• 市場分析、洞察與預測
• 學術研究機構
• 製藥和生物技術公司
• 醫院和診所
• 診斷實驗室
• 受託研究機構（CRO）

第8章 全球qPCR試劑市場：依等級分類

• 市場分析、洞察與預測
• 研究級
• 臨床等級
• 符合監管規定的等級

第9章 全球qPCR試劑市場：依地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 以色列
  • 南非
  • 其他中東和非洲國家

第10章 競爭格局

• 最新趨勢
• 公司分類
• 供應鏈和分銷通路合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第11章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Agilent Technologies
  • Bio-Rad Laboratories
  • Roche
  • Thermo Fisher
  • Cole-Parmer
  • Norgen BIoTek
  • Promega
  • Qiagen
  • Sigma-Aldrich
  • Takara Bio

The qPCR Reagents Market size is expected to reach USD 8.47 Billion in 2034 from USD 3.95 Billion (2025) growing at a CAGR of 8.84% during 2026-2034.

The global qPCR reagents market is growing significantly due to increasing demand for molecular diagnostic testing worldwide. Rising prevalence of infectious diseases has boosted testing volumes in clinical laboratories. Expanding research activities in genomics and biotechnology are driving reagent consumption. The pandemic accelerated awareness and adoption of advanced molecular diagnostic technologies. These combined factors are strengthening overall market growth.

Key drivers include advancements in personalized medicine and precision diagnostics. Pharmaceutical and biotechnology companies rely heavily on qPCR for drug development and validation processes. Growing government funding for life science research is increasing laboratory investments. Technological improvements have enhanced assay sensitivity, accuracy, and reliability. Expansion of diagnostic infrastructure in emerging economies further supports demand.

Future prospects remain promising with increasing applications in oncology and genetic testing. Automation in laboratories will significantly improve throughput and efficiency. Development of multiplex assays will offer additional growth opportunities. Emerging markets are strengthening healthcare infrastructure investments. Continuous innovation in molecular biology tools will sustain long-term expansion.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product Type

• Master Mix
• Primers and Probes
• Enzymes
• Buffers
• Other Components

By Application

• Clinical Diagnostics
• Pharmaceutical Research
• Environmental Monitoring
• Agricultural Biotechnology
• Food Safety Testing

By Technology

• Real-Time PCR (qPCR)
• Digital PCR (dPCR)
• Multiplex PCR
• Reverse Transcription PCR (RT-PCR)

By End User

• Academic and Research Institutions
• Pharmaceutical and Biotechnology Companies
• Hospitals and Clinics
• Diagnostic Laboratories
• Contract Research Organizations (CROs)

By Grade

• Research Grade
• Clinical Grade
• Regulatory Compliant Grade

COMPANIES PROFILED

• Agilent Technologies, BioRad Laboratories, Roche, Thermo Fisher, ColeParmer, Norgen Biotek, Promega, Qiagen, SigmaAldrich, Takara Bio
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL QPCR REAGENTS MARKET: BY PRODUCT TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product Type
• 4.2. Master Mix Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Primers and Probes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Buffers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Other Components Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL QPCR REAGENTS MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Clinical Diagnostics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Pharmaceutical Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Environmental Monitoring Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Agricultural Biotechnology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Food Safety Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL QPCR REAGENTS MARKET: BY TECHNOLOGY 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Technology
• 6.2. Real-Time PCR (qPCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Digital PCR (dPCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Multiplex PCR Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Reverse Transcription PCR (RT-PCR) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL QPCR REAGENTS MARKET: BY END USER 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast End User
• 7.2. Academic and Research Institutions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Pharmaceutical and Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.4. Hospitals and Clinics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.5. Diagnostic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.6. Contract Research Organizations (CROs) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL QPCR REAGENTS MARKET: BY GRADE 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Grade
• 8.2. Research Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Clinical Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.4. Regulatory Compliant Grade Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL QPCR REAGENTS MARKET: BY REGION 2022-2034(USD MN)

• 9.1. Regional Outlook
• 9.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.2.1 By Product Type
  • 9.2.2 By Application
  • 9.2.3 By Technology
  • 9.2.4 By End User
  • 9.2.5 By Grade
  • 9.2.6 United States
  • 9.2.7 Canada
  • 9.2.8 Mexico
• 9.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.3.1 By Product Type
  • 9.3.2 By Application
  • 9.3.3 By Technology
  • 9.3.4 By End User
  • 9.3.5 By Grade
  • 9.3.6 United Kingdom
  • 9.3.7 France
  • 9.3.8 Germany
  • 9.3.9 Italy
  • 9.3.10 Russia
  • 9.3.11 Rest Of Europe
• 9.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.4.1 By Product Type
  • 9.4.2 By Application
  • 9.4.3 By Technology
  • 9.4.4 By End User
  • 9.4.5 By Grade
  • 9.4.6 India
  • 9.4.7 Japan
  • 9.4.8 South Korea
  • 9.4.9 Australia
  • 9.4.10 South East Asia
  • 9.4.11 Rest Of Asia Pacific
• 9.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.5.1 By Product Type
  • 9.5.2 By Application
  • 9.5.3 By Technology
  • 9.5.4 By End User
  • 9.5.5 By Grade
  • 9.5.6 Brazil
  • 9.5.7 Argentina
  • 9.5.8 Peru
  • 9.5.9 Chile
  • 9.5.10 South East Asia
  • 9.5.11 Rest of Latin America
• 9.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 9.6.1 By Product Type
  • 9.6.2 By Application
  • 9.6.3 By Technology
  • 9.6.4 By End User
  • 9.6.5 By Grade
  • 9.6.6 Saudi Arabia
  • 9.6.7 UAE
  • 9.6.8 Israel
  • 9.6.9 South Africa
  • 9.6.10 Rest of the Middle East And Africa

Chapter 10. COMPETITIVE LANDSCAPE

• 10.1. Recent Developments
• 10.2. Company Categorization
• 10.3. Supply Chain & Channel Partners (based on availability)
• 10.4. Market Share & Positioning Analysis (based on availability)
• 10.5. Vendor Landscape (based on availability)
• 10.6. Strategy Mapping

Chapter 11. COMPANY PROFILES OF GLOBAL QPCR REAGENTS INDUSTRY

• 11.1. Top Companies Market Share Analysis
• 11.2. Company Profiles
  • 11.2.1 Agilent Technologies
  • 11.2.2 Bio-Rad Laboratories
  • 11.2.3 Roche
  • 11.2.4 Thermo Fisher
  • 11.2.5 Cole-Parmer
  • 11.2.6 Norgen Biotek
  • 11.2.7 Promega
  • 11.2.8 Qiagen
  • 11.2.9 Sigma-Aldrich
  • 11.2.10 Takara Bio